154 clinical trials matched your search for Cancer. You can click one of the clinical trials below for more information, or click the Search Again button to enter different search text.

Search Again
Condition Study Title Investigator
Cancer A Study for Patients with Advanced Melanoma, Solid Tumors or Lymphoma Using Study Drug Pembrolizumab Nobuko Hijiya, MD
Cancer Study Of Palbociclib Combined With Chemotherapy In Pediatric Patients With Recurrent/Refractory Solid Tumors Nobuko Hijiya, MD
Cancer Study of Relatlimab and Nivolumab in Patients Under 30 Years Old with Classical Hodgkin Lymphoma (cHL) and Non-Hodgkin Lymphoma (NHL) Nobuko Hijiya, MD
Childhood Leukemia Study of Quizartinib in Combination with Chemotherapy for Children and Young Adults with Recurrent /Refractory Acute Myeloid Leukemia (AML) Luca Szalontay, MD
Childhood Leukemia PEPN2113: Study of Uproleselan in Children with AML, MDS, or MPAL Nobuko Hijiya, MD
Cancer Collecting and growing patient tumor and blood cells from extra tissue to learn about cancer and test new drugs Bret Taback, MD
Pancreatic Cancer The Cancer of the Pancreas Screening-5 Study (CAPS5 Study) Fay Kastrinos, MD
Cancer Identification of Targets for Cancer Treatment Andrea Califano, PhD
Lymphoma Study of Drug for Solid Organ Transplant Subjects with Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease Ran Reshef, MD
Breast Cancer Study to Predict Your Therapeutic Response (I-SPY 2 Trial) Meghna Trivedi, MD
Pancreatic Cancer Study of Stimulation with Bethanechol in Pancreatic Adenocarcinoma Prior to Surgery Susan Bates, MD
Gynecologic Cancer Study of REGN4018 Alone or in Combination with Cemiplimab in Patients with Ovarian Cancer June Hou, MD
Cancer Clinical Trial Screening Tool to Address Cancer Health Disparities Katherine Crew, MD
Prostate Cancer IRONMAN: International Registry for Men with Advanced Prostate Cancer Mark Stein, MD
Breast Cancer Study Comparing Survival of Patients Monitored with Serum Tumor Marker Directed Disease Versus Usual Care in Metastatic Breast Cancer Melissa Accordino, MD
Kidney Cancer Study of Spartalizumab and Canakinumab Prior to Radical Nephrectomy in Patients with Localized Clear Cell Renal Cell Carcinoma Karie D. Runcie, MD
Prostate Cancer Study of REGN5678 (Anti-PSMAxCD28) With Cemiplimab (Anti-PD-1) in Patients With Metastatic Castration-resistant Prostate Cancer Mark Stein, MD
Cancer Study of Ipilimumab, Cabozantinib, and Nivolumab in Rare Genitourinary Cancers (ICONIC) Mark Stein, MD
Brain Tumors Study to Evaluate Multiple Treatments for Patients with Newly Diagnosed or Recurrent GBM Andrew Lassman, MD
Cancer Study of IDE196 in Patients with Solid Tumors Alexander Wei, MD
Cancer Study of A Vaccine Targeting Shared Neoantigens in Subjects with Advanced Solid Tumors Brian Henick, MD
Pancreatic Cancer Study to Evaluate AB680 Combination Therapy in Participants with Gastrointestinal Malignancies Gulam Manji, MD, PhD
Cancer Study of Rituximab or Tocilizumab for Patients With Steroid-Dependent Immune-Related Adverse Events (irAEs) Brian Henick, MD
Breast Cancer Addinex-Opioid Dispenser for Post-Op Pain in Cancer Patients Dawn Hershman, MD
Cancer Safety Study of PBCAR0191 in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma and r/r B-cell Acute Lymphoblastic Leukemia Ran Reshef, MD
Lung Cancer Study of Therapies in Participants with Resectable (removable) and Untreated Non-Small Cell Lung Cancer (NSCLC) Catherine Shu, MD
Lung Cancer Testing Whether the Use of Brain Scans Alone vs. Brain Scans Plus Brain Radiation Affects Lifespan in Patients With Small Cell Lung Cancer Simon Cheng, MD, PhD
Cancer Study of Safety and Tolerability of BCA101 Alone and in Combination With Pembrolizumab in Patients With EGFR-driven Advanced Solid Tumors Catherine Shu, MD
Breast Cancer MiChoice: Making Informed Choices on Incorporating Chemoprevention Into Care Katherine Crew, MD
Cancer Study of ST101 in Patients with Advanced Solid Tumors Fabio Iwamoto, MD
Pancreatic Cancer Chemo4METPANC: Combination of Chemotherapy, Motixafortide, and Cemiplimab in Patients with Pancreatic Cancer Gulam Manji, MD, PhD
Cancer Study of IMC-F106C Alone and in Combination With Checkpoint Inhibitors in Participants with Advanced Cancers Benjamin Izar, MD
Kidney Cancer Cyto-KIK Trial: CYTO Reductive Surgery in Kidney Cancer Plus Immunotherapy and Targeted Kinase Inhibition Mark Stein, MD
Cancer Study of Peposertib With Avelumab and Radiation Therapy for Advanced/Metastatic Solid Tumors and Hepatobiliary Malignancies Susan Bates, MD
Cancer A Study of BMS-986340 Alone and in Combination With Nivolumab in Participants With Advanced Solid Tumors Ryan Moy, MD
Pancreatic Cancer Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for Locally Advanced Pancreatic Cancer (TIGeR-PaC) Susan Bates, MD
Cancer Study of Investigational Drug (RP-6306) in Patients with Advanced Cancer Ryan Moy, MD
Cancer Study of BAY 1895344 in Combination with Chemotherapy for Patients with Advanced Cancer Mark Stein, MD
Cancer Study of Financial Navigator Addressing Cancer-Related Financial Hardship in Cancer Patients and Their Spouses Dawn Hershman, MD
Breast Cancer Study of Symptom Monitoring using Young, Empowered & Strong (YES) Web Portal for Breast Cancer Survivors Dawn Hershman, MD
Brain Tumors Study of Vismodegib and GSK2256098 to Shrink Tumors in Patients with Meningioma Mary Welch, MD
Leukemia Study of BGB-11417 in Patients with Leukemia Nicole Lamanna, MD
Pancreatic Cancer Study of Bethanechol in Combination with Chemotherapy for Patients with Pancreatic Cancer Susan Bates, MD
Brain Cancer Study to Evaluate Multiple Treatments for Patients with Newly Diagnosed or Recurrent GBM Andrew Lassman, MD
Brain Cancer Study of Vismodegib and GSK2256098 to Shrink Tumors in Patients with Meningioma Mary Welch, MD
Cancer Study of IDE397 in Patients with Advanced Solid Tumors Benjamin Herzberg, MD
Breast Cancer Study of T-DM1 in Combination with Tucatinib for Patients with HER2-Positive Breast Cancer Julia McGuinness, MD
Leukemia Study of TSC 100 & TSC 101 in Patients with Leukemia Undergoing Haploidentical Allogeneic Blood Stem Cell Transplantation (HCT) Ran Reshef, MD
Brain Cancer Study of Chemotherapy Drug, Lomustine, in Addition to Temozolomide in Patients with Glioblastoma (GBM) Fabio Iwamoto, MD
Brain Tumors Study of Chemotherapy Drug, Lomustine, in Addition to Temozolomide in Patients with Glioblastoma (GBM) Fabio Iwamoto, MD
Breast Cancer Intervention to Improve Medication Scheduling for Patients with Breast Cancer Dawn Hershman, MD
Cancer Study of CS5001 in Patients with Advanced Solid Tumors Hua-Jay Cherng, MD
Breast Cancer Study of RLY-2608 in Patients with Breast Cancer Julia McGuinness, MD
Prostate Cancer Study of XmAb20717 Alone or in Combination with Chemotherapy in Patients with Prostate Cancer Mark Stein, MD
Brain Cancer Study of Immune Therapy Drugs in Addition to the Usual Radiation Therapy for Patients with Brain Cancer (Glioblastoma) Fabio Iwamoto, MD
Brain Tumors Study of Immune Therapy Drugs in Addition to the Usual Radiation Therapy for Patients with Brain Cancer (Glioblastoma) Fabio Iwamoto, MD
Breast Cancer Study of Radiation Therapy Alone or in Combination With Olaparib for Patients with Inflammatory Breast Cancer (IBC) Eileen Connolly, MD, PhD
Lymphoma Study of Venetoclax in Addition to Usual Treatment for Patients with Waldenstrm's Macroglobulinemia (WM)/Lymphoplasmacytic Lymphoma (LPL) Divaya Bhutani, MD
Lymphoma Study of CC-486 (Oral Azacitidine) Alone or in Combination with Chemo in Participants with Diffuse Large B Cell Lymphoma (DLBCL) (Ages 75+) Jennifer Amengual, MD
Breast Cancer Study of GLSI-100 in Female Patients with Breast Cancer Julia McGuinness, MD
Cancer Study of BT7480 in Patients with Advanced Cancer Mark Stein, MD
Cancer Study of ASP3082 in Patients with Advanced Cancer with a KRAS G12D Mutation Benjamin Herzberg, MD
Lymphoma Study of Duvelisib or Azacitidine in Addition to Chemotherapy in Patients with Peripheral T-Cell Lymphoma (PTCL) Jennifer Amengual, MD
Cancer Study of STK-012 Alone or in Combination with Pembrolizumab (KEYTRUDA) in Patients with Advanced Solid Tumors Benjamin Izar, MD
Sarcoma Study of AGEN1181 Alone or in Combination with Balstilimab in Patients with Advanced Sarcoma Brian Henick, MD
Breast Cancer Study of Denosumab in Women with Breast Cancer who Carry the BRCA1 Mutation Katherine Crew, MD
Lymphoma Study of Lenalidomide in Combination with Chemotherapy in Patients with HTLV-Associated Adult T-Cell Leukemia-Lymphoma (ATLL) Jennifer Amengual, MD
Cancer Study of 68Ga-FAP-2286 and 177Lu-FAP-2286 in Patients with Advanced Cancer Ryan Moy, MD
Melanoma Study of DYP688 in Patients with Melanoma Alexander Wei, MD
Gastrointestinal Study of Domvanalimab and Zimberelimab Alone or in Combination with Chemotherapy in Patients with Upper Gastrointestinal Cancers (UGI) Ryan Moy, MD
Prostate Cancer Study of CC-94676 in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC) Karie D. Runcie, MD
Skin Cancer Study of RP1 in Organ Transplant Patients with Skin Cancer Shaheer Khan, DO
Pancreatic Cancer Study of SBP-101 Alone or in Combination with Chemotherapy in Patients with Untreated Pancreatic Ductal Adenocarcinoma (PDAC) Gulam Manji, MD, PhD
Cancer Study of BLU-222 Alone or in Combination with Other Cancer Therapy for Patients with Advanced Cancer Brian Henick, MD
Prostate Cancer Study of JNJ-78278343 in Patients with Advanced Prostate Cancer Mark Stein, MD
Cancer Study of RMC-6291 in Patients with Advanced Solid Tumors Benjamin Herzberg, MD
Lung Cancer ApricityCare: Smartphone App Study for Patients with Non-Small Cell Lung Cancer (NSCLC) Brian Henick, MD
Prostate Cancer Study of Whole-Food Plant-Based Diet (WFPBD) to Control Weight in Overweight/Obese Men with Prostate Cancer Mark Stein, MD
Brain Cancer Study of Tirabrutinib in Patients with Primary Central Nervous System Lymphoma (PCNSL) Fabio Iwamoto, MD
Brain Tumors Study of Tirabrutinib in Patients with Primary Central Nervous System Lymphoma (PCNSL) Fabio Iwamoto, MD
Lung Cancer Study of Savolitinib in Combination with Osimertinib vs. Chemotherapy in Patients with Non-Small Cell Lung Cancer (NSCLC) Catherine Shu, MD
Prostate Cancer Study of VTP-850 in Male Patients with Prostate Cancer Whose Prostate-Specific Antigen (PSA) Levels Have Risen Mark Stein, MD
Gastrointestinal Study of DKN-01 in Combination with Tislelizumab & Chemotherapy in Patients with Advanced Gastric or Gastroesophageal Junction (GEJ) Cancer Ryan Moy, MD
Melanoma Study of Fianlimab and Cemiplimab vs. Pembrolizumab in Patients with Resected High-Risk Melanoma Benjamin Izar, MD
Leukemia Study of SEA-CD70 in Patients with Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) Joseph Jurcic, MD
Breast Cancer Study of Breast Cancer in Black Women Lauren Houghton, PhD
Healthy Volunteers Study of Breast Cancer in Black Women - Healthy Controls Lauren Houghton, PhD
Cancer Study of XL092 Alone or in Combination with Anticancer Therapy in Patients with Unresectable orMetastatic Solid Tumors Karie D. Runcie, MD
Cancer Study of MRT-2359 in Patients with Solid Tumors Benjamin Herzberg, MD
Gynecologic Cancer Comparing Investigational Surgery to Laparotomy After Chemotherapy in Women with Epithelial Ovarian Cancer (EOC) Jason Wright, MD
Cancer Study of RMC-6236 in Patients with Solid Tumors with a KRAS Mutation Benjamin Herzberg, MD
Lymphoma Study of ONO-4685 in Patients with T-Cell Lymphoma Barbara Pro, MD
Gynecologic Cancer Comparing Surgeries to Reduce the Risk of Ovarian Cancer in Women with BRCA1 Mutations Jason Wright, MD
Lymphoma Study of Axi-cel vs. Chemotherapy in Patients with High-Risk Large B-Cell Lymphoma Ran Reshef, MD
Lymphoma Study of Relatlimab and Nivolumab in Patients Under 30 Years Old with Classical Hodgkin Lymphoma (cHL) and Non-Hodgkin Lymphoma (NHL) Nobuko Hijiya, MD
Pancreatic Cancer Study of Zimberelimab in Patients with Advanced Pancreatic Cancer who are Eligible for Surgery Gulam Manji, MD, PhD
Lung Cancer Study of Osimertinib (TAGRISSOTM) in Patients with Non-Small Cell Lung Cancer (NSCLC) Catherine Shu, MD
Prostate Cancer Study of JNJ-87189401 in Combination with JNJ 78278343 in Patients with Prostate Cancer Mark Stein, MD
Gynecologic Cancer Study of TransCon IL-2 / vs. TransCon TLR7/8 Agonist in Patients with Gynecologic Cancer June Hou, MD
Lymphoma Study of KITE-363 vs. KITE-753 in Patients with B-cell Lymphoma Ran Reshef, MD
Cancer Study of NDI-101150 Alone or in Combination with Pembrolizumab in Patients with Solid Tumors Ryan Moy, MD
Cancer Study of XmAb808 in Combination with Pembrolizumab in Patients with Advanced Cancer Mark Stein, MD
Cancer Cooling and Compression to Prevent Nerve Damage During Chemotherapy Melissa Accordino, MD
Brain Cancer Study of PF-07799544 in Patients with Solid Brain Tumors Aya Haggiagi, MD
Brain Tumors Study of PF-07799544 in Patients with Solid Brain Tumors Aya Haggiagi, MD
Lymphoma Study of Tazemetostat or Zanubrutinib for Patients with Large B-Cell Lymphoma (LBCL) Jennifer Amengual, MD
Lung Cancer Study of JNJ-86974680 Alone or in Combination with Cetrelimab and Radiotherapy in Patients with Non-Small Cell Lung Cancer (NSCLC) Brian Henick, MD
Lung Cancer Study of CLN-081 in Patients with Non-Small Cell Lung Cancer (NSCLC) Catherine Shu, MD
Prostate Cancer Study of Apalutamide Alone or in Combination with ADT in Patients with Metastatic Castration-Sensitive Prostate Cancer (mCSPC) Karie D. Runcie, MD
Cancer Study of T Plex in Patients with Advanced or Metastatic Solid Tumors Brian Henick, MD
Pancreatic Cancer Study of Autogene Cevumeran & Atezolizumab Alone or in Combination with mFOLFIRINOX in Patients with Resected Pancreatic Cancer (PDAC) Gulam Manji, MD, PhD
Lymphoma Study of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma Barbara Pro, MD
Heart Disease The DREAM Sleep Health Clinical Trial Nour Makarem, PhD
Prostate Cancer Study of ONC-392 in Combination with PLUVICTO in Male Patients with Prostate Cancer Mark Stein, MD
Breast Cancer Improving Medication Barriers Among Patients with Metastatic Breast Cancer Claire Sathe, MD
Cancer Study of HRO761 Alone or in Combination with Tislelizumab or Irinotecan in Patients with Solid Tumors Edmond Chan, MD
Lung Cancer Study of Ramucirumab Plus Pembrolizumab vs. Standard of Care in Patients with Non-Small Cell Lung Cancer (NSCLC) Stephanie Smith-Marrone, MD
Multiple Myeloma Study of Teclistamab In Patients with Multiple Myeloma Divaya Bhutani, MD
Multiple Myeloma Study of REGN5458 in Patients with Multiple Myeloma Rajshekhar Chakraborty, MD
Breast Cancer Impact of Aromatase Inhibitors on Daily Activities for Individuals with Breast Cancer Rochelle Mendonca, PhD
Cancer Study of CTX-009 Alone or in Combination with Paclitaxel in Patients with Cancer Linda Wu, MD
Lymphoma Treatment After CAR T-Cell Therapy for Patients with Diffuse Large B-cell Lymphoma (DLBCL) Hua-Jay Cherng, MD
Pancreatic Cancer Study of ASP2138 in Patients with Stomach or Pancreatic Cancer Ryan Moy, MD
Gastrointestinal Study of ASP2138 in Patients with Stomach or Pancreatic Cancer Ryan Moy, MD
Multiple Myeloma Study of BMS-986393 in Patients with Multiple Myeloma (MM) Divaya Bhutani, MD
Gastrointestinal The Janus Rectal Cancer Trial Yoanna Pumpalova, MD
Bladder Cancer Study of BT8009 in Combination with Pembrolizumab in Patients with Urothelial Cancer Alexander Wei, MD
Cancer Study of DB-1311 in Patients with Solid Tumors Brian Henick, MD
Multiple Myeloma Study of Linvoseltamab in Patients with Multiple Myeloma (NDMM) Rajshekhar Chakraborty, MD
Lung Cancer Study of Adagrasib Alone or in Combination with Nivolumab Non-Small Cell Lung Cancer (NSCLC) Benjamin Herzberg, MD
Cancer Study of AMG 193 and IDE397 in Patients with Solid Tumors Benjamin Herzberg, MD
Cancer Study of PRT3789 in Patients with Advanced or Metastatic Solid Tumors with a SMARCA4 Mutation Benjamin Herzberg, MD
Cancer Study of RMC-6291 and RMC 6236 in Patients with Solid Tumors Benjamin Herzberg, MD
Cancer Study of RP-1664 in Patients with Solid Tumors Benjamin Herzberg, MD
Lung Cancer Study of Osimertinib in Patients with Non-Small Cell Lung Cancer (NSCLC) Catherine Shu, MD
Gynecologic Cancer Vaginal Surgical Sample Collection Jason Wright, MD
Brain Cancer Study of Sonocloud 9 in Patients with Glioblastoma (GBM) Brian Gill, MD
Brain Tumors Study of Sonocloud 9 in Patients with Glioblastoma (GBM) Brian Gill, MD
Gastrointestinal Study of Defactinib & Avutometinib in Patients with Stomach Cancer Ryan Moy, MD
Lung Cancer Study of Durvalumab in Patients with Non-Small Cell Lung Cancer (NSCLC) Benjamin Herzberg, MD
Cancer Study of SGN-B6A in Advanced Solid Tumors Benjamin Herzberg, MD
Prostate Cancer Study of HB-302/HB-301 in Patients with Prostate Cancer Mark Stein, MD
Brain Cancer Study of Eflornithine & Temozolomide in Patients with Glioblastoma Multiforme (GBM) Maria Diaz Ordonez, MD
Brain Tumors Study of Eflornithine & Temozolomide in Patients with Glioblastoma Multiforme (GBM) Maria Diaz Ordonez, MD
Gynecologic Cancer Study of ACR-368 (Prexasertib) in Patients with Ovarian Carcinoma, Endometrial Adenocarcinoma, or Urothelial Carcinoma June Hou, MD
Brain Cancer Study of AZD9574 in Patients with Brain Cancer Maria Diaz Ordonez, MD
Brain Tumors Study of AZD9574 in Patients with Brain Cancer Maria Diaz Ordonez, MD
Lung Cancer Study of Atezolizumab in Patients with Early Stage Non-Small Cell Lung Cancer (NSCLC) Simon Cheng, MD, PhD
Gastrointestinal Study of LBL-007 & Tislelizumab in Patients with Colon Cancer Yoanna Pumpalova, MD
Cancer Study of Drug in Patients with Advanced Solid Malignancies and Lymphoma June Hou, MD
Multiple Myeloma Study of Venetoclax in Combination with Dexamethasone in Patients with Light Chain Amyloidosis Rajshekhar Chakraborty, MD
Diabetes Temporary Insulin Resistance Joshua Cook, MD, PhD
Healthy Volunteers Temporary Insulin Resistance Joshua Cook, MD, PhD
Obesity Temporary Insulin Resistance Joshua Cook, MD, PhD